Tenecteplase 40mg Injection
Nuclear Power Corporation of India Limited · Pharmaceuticals · open
Key facts
- Closing date: 29 Jul 2026
- Status: open
- Department: Department of Atomic Energy
- Office: NAPS
Description
Tender for supply of Tenecteplase 40mg Injection with a total quantity of 4 units, issued by the Department of Atomic Energy, Nuclear Power Corporation of India Limited. The bid validity is 90 days from the end date, with a bid opening scheduled for 29-07-2026 at 11:30 AM. The tender includes details on technical specifications, payment terms, and purchase preferences, with no EMD or ePBG required.
Eligibility & requirements
- Startup relaxation: Yes
- MSE relaxation: Yes
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: value wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (1)
- Tenecteplase 40mg Injection — Qty: 4 unit
1 tender document(s) available — sign up to download.